Two Major Cancer Centers Announce Appointments of New Directors - Summary - MDSpire
Feature

Two Major Cancer Centers Announce Appointments of New Directors

Last week, Dartmouth Cancer Center and Fox Chase Cancer Center announced the appointments of new directors—both experts in the treatment of lung cancer.

Share

Dartmouth Cancer Center (DCC) appointed Roy S. Herbst, MD, PhD as its new director to enhance cancer research and treatment efforts starting July 13. Herbst, previously from Yale, aims to lead DCC in integrating cancer care and research across Dartmouth Health and expand advanced treatment access. Simultaneously, Robert A. Winn, MD is set to become the director of Fox Chase Cancer Center, focusing on groundbreaking oncology research and community-based cancer care innovation. Both leaders are expected to drive advancements in cancer care nationally.

Original Source(s)

Two Major Cancer Centers Announce Appointments of New Directors

  • by The ASCO Post Staff

  • April 7, 2026

Related Content

Analysis Shows Nearly 7% of Global Clinical Trials Are Impacted by Middle East Disruption

Oncology trials account for a substantial proportion of impacted activity, with non–small cell lung cancer representing the most affected indication, followed by breast cancer.

Perioperative Enfortumab Vedotin Plus Pembrolizumab in Cisplatin-Ineligible Bladder Cancer

As reported in The New England Journal of Medicine by Vulsteke et al, the phase III KEYNOTE-905/EV-303 trial has shown improved event-free and overall survival with the addition of perioperative enfor...

Can ctDNA Negativity Predict Metastasis-Free Survival in Muscle-Invasive Bladder Cancer?

Circulating tumor DNA (ctDNA) may be used to predict metastatic risk and identify which patients with muscle-invasive bladder cancer are more likely to benefit from a bladder-sparing treatment approac...